Business Wire

Perimeter Medical Imaging AI Announces Important Milestone in ATLAS AI Project With FDA Investigational Device Exemption (IDE) Approval to Launch Clinical Trial Using Perimeter B-Series OCT With ImgAssist AI in Breast Conservation Surgery

Pivotal study to determine the impact of Perimeter’s novel OCT imaging technology combined with artificial intelligence on positive margin rates for patients with breast cancer TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging A